patent for semaglutide Last week's expiry of the semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions Semaglutide's patent expires today. What

Understanding the distinct pharmacological mechanisms and therapeutic indications of these medications is essential when considering their concurrent use, as patients with ADHD may also struggle with weight management issues requiring medical intervention

With these new drugs, there has been a significant paradigm shift

The logic is that bupropion + naltrexone (Contrave) addresses reward-driven eating and appetite, while topiramate independently suppresses cravings through a different brain mechanism

The absence of salt content in semaglutide, or ensuring that semaglutide is free from salts, is important for a few reasons related to its stability, efficacy, and how the body absorbs and reacts to the drug: These factors combined ensure that compounded semaglutide remains a highly effective and safer treatment option Semaglutide compounded with salts